GGrantIndex
← Leaderboards

Nazira El-Hage

Virginia Commonwealth University

$4,324,284
Attributed
$6,251,086
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,251,086 · 7

By mechanism

R01$4,753,382 · 3
R21$1,200,324 · 3
R03$297,380 · 1

Top collaborators

Most similar at Virginia Commonwealth University

Same institution · by research overlap

Others in their field

Top investigators on “Brain

Research focus

BrainMorphineOpioidResponseProteinsAutopsyCellsInsightPersonsTissuesInfectionViralNeurogliaAutophagocytosisPathologyPathway InteractionsSignal TransductionPharmaceutical PreparationsNeuronsFunctional DisorderHiv-1OpiatesPlayHiv Infections

Grant awards (22)

Title: Pharmacokinetic, pharmacodynamic , and toxicological interactions among Opioids and Cabotegravir$694,456
R01 · FY2025 · DA · contact PI
Function of astrocytes autophagy in brain homeostasis and opioid-induced maladaptive behavior and addiction, in the context of HIV$349,323
R01 · FY2025 · DA · contact PI
Reduction of the Beclin1-BCL2 complex in the prevention of HIV and comorbidities associated with aging$185,000
R21 · FY2025 · AG
Title: Pharmacokinetic, pharmacodynamic , and toxicological interactions among Opioids and Cabotegravir$356,454
R01 · FY2024 · DA · contact PI
Function of astrocytes autophagy in brain homeostasis and opioid-induced maladaptive behavior and addiction, in the context of HIV$349,424
R01 · FY2024 · DA · contact PI
Reduction of the Beclin1-BCL2 complex in the prevention of HIV and comorbidities associated with aging$222,000
R21 · FY2024 · AG
Title: Pharmacokinetic, pharmacodynamic , and toxicological interactions among Opioids and Cabotegravir$365,335
R01 · FY2023 · DA · contact PI
Function of astrocytes autophagy in brain homeostasis and opioid-induced maladaptive behavior and addiction, in the context of HIV$360,823
R01 · FY2023 · DA · contact PI
Title: Pharmacokinetic, pharmacodynamic , and toxicological interactions among Opioids and Cabotegravir$374,030
R01 · FY2022 · DA · contact PI
Develop and evaluate efficacy of nanoformulated siBeclin1 delivered intranasally to eliminate HIV in brain$224,556
R21 · FY2020 · MH · contact PI
Develop and evaluate efficacy of nanoformulated siBeclin1 delivered intranasally to eliminate HIV in brain$206,268
R21 · FY2019 · MH · contact PI
Role of Autophagy in Microglia-induced NeuroAIDS in Substance Abuse$400,200
R01 · FY2017 · DA · contact PI
Impact of μ-opioid receptor (MOR) splice variant interactions with the chemokine receptor CCR5 in the context of morphine and HIV-1 entry inhibitor therapy$181,250
R21 · FY2017 · DA · contact PI
Role of Autophagy in Microglia-induced NeuroAIDS in Substance Abuse$358,875
R01 · FY2016 · DA · contact PI
Impact of μ-opioid receptor (MOR) splice variant interactions with the chemokine receptor CCR5 in the context of morphine and HIV-1 entry inhibitor therapy$181,250
R21 · FY2016 · DA · contact PI
Role of Autophagy in Microglia-induced NeuroAIDS in Substance Abuse$37,700
R01 · FY2016 · DA · contact PI
Role of Autophagy in Microglia-induced NeuroAIDS in Substance Abuse$357,062
R01 · FY2015 · DA · contact PI
Role of Autophagy in Microglia-induced NeuroAIDS in Substance Abuse$255,200
R01 · FY2014 · DA · contact PI
Role of Autophagy in Microglia-induced NeuroAIDS in Substance Abuse$113,250
R01 · FY2014 · DA · contact PI
Role of Autophagy in Microglia-induced NeuroAIDS in Substance Abuse$381,250
R01 · FY2013 · DA · contact PI
Oxidative damage and proteasome activity: Role of opioid in HIV-HCV infection$148,005
R03 · FY2010 · DA · contact PI
Oxidative damage and proteasome activity: Role of opioid in HIV-HCV infection$149,375
R03 · FY2009 · DA · contact PI